Genetec Corporation (TYO:4492)
Japan · Delayed Price · Currency is JPY 389.00
+10.00 (2.64%)
Jul 30, 2026, 3:30 PM JST
Genetec Balance Sheet
Financials in millions JPY. Fiscal year is April - March.
Millions JPY. Fiscal year is Apr - Mar.
Assets
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash & Equivalents | 1,597 | 1,985 | 1,168 | 1,075 | 1,044 |
Cash & Short-Term Investments | 1,597 | 1,985 | 1,168 | 1,075 | 1,044 |
Cash Growth | -19.55% | 69.95% | 8.65% | 2.97% | -29.51% |
Accounts Receivable | 2,429 | 2,118 | 1,435 | 1,247 | 1,038 |
Other Receivables | 8 | 11 | 2 | 5 | 149 |
Receivables | 2,437 | 2,129 | 1,437 | 1,252 | 1,187 |
Inventory | 185 | 245 | 242 | 103 | 60 |
Other Current Assets | 271 | 261 | 398 | 395 | 179 |
Total Current Assets | 4,490 | 4,620 | 3,245 | 2,825 | 2,470 |
Property, Plant & Equipment | 714 | 682 | 108 | 122 | 177 |
Long-Term Investments | 194 | 187 | 137 | 139 | 125 |
Goodwill | 770 | 1,003 | 626 | 706 | 187 |
Other Intangible Assets | 422 | 272 | 148 | 104 | 89 |
Long-Term Deferred Tax Assets | 319 | 383 | 255 | 223 | 203 |
Other Long-Term Assets | 3 | 2 | 1 | 2 | 2 |
Total Assets | 6,912 | 7,149 | 4,520 | 4,121 | 3,253 |
Liabilities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Accounts Payable | 495 | 516 | 347 | 306 | 208 |
Accrued Expenses | 325 | 310 | 325 | 261 | 223 |
Short-Term Debt | 1,300 | 1,200 | 400 | 500 | - |
Current Portion of Long-Term Debt | 247 | 280 | 60 | 79 | 29 |
Current Portion of Leases | 4 | 2 | - | - | - |
Current Income Taxes Payable | 452 | 802 | 451 | 240 | 457 |
Other Current Liabilities | 194 | 223 | 176 | 115 | 122 |
Total Current Liabilities | 3,017 | 3,333 | 1,759 | 1,501 | 1,039 |
Long-Term Debt | 514 | 772 | 180 | 396 | 21 |
Long-Term Leases | 8 | 4 | - | - | - |
Pension & Post-Retirement Benefits | 633 | 622 | 367 | 356 | 332 |
Long-Term Deferred Tax Liabilities | - | 1 | - | 1 | - |
Other Long-Term Liabilities | 14 | 14 | - | 2 | 2 |
Total Liabilities | 4,186 | 4,746 | 2,306 | 2,256 | 1,394 |
Shareholders' Equity
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Common Stock | 388 | 379 | 370 | 366 | 358 |
Additional Paid-In Capital | 528 | 517 | 503 | 498 | 487 |
Retained Earnings | 1,811 | 1,508 | 1,344 | 1,005 | 1,019 |
Treasury Stock | -2 | -3 | -4 | -4 | -5 |
Comprehensive Income & Other | 1 | 2 | 1 | - | - |
Shareholders' Equity | 2,726 | 2,403 | 2,214 | 1,865 | 1,859 |
Total Liabilities & Equity | 6,912 | 7,149 | 4,520 | 4,121 | 3,253 |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Total Debt | 2,073 | 2,258 | 640 | 975 | 50 |
Net Cash (Debt) | -476 | -273 | 528 | 100 | 994 |
Net Cash Growth | - | - | 428.00% | -89.94% | -29.30% |
Net Cash Per Share | -40.83 | -23.49 | 45.57 | 8.70 | 87.86 |
Filing Date Shares Outstanding | 11.57 | 11.49 | 11.4 | 11.35 | 11.25 |
Total Common Shares Outstanding | 11.57 | 11.49 | 11.4 | 11.35 | 11.25 |
Working Capital | 1,473 | 1,287 | 1,486 | 1,324 | 1,431 |
Book Value Per Share | 235.71 | 209.06 | 194.28 | 164.25 | 165.30 |
Tangible Book Value | 1,534 | 1,128 | 1,440 | 1,055 | 1,583 |
Tangible Book Value Per Share | 132.64 | 98.13 | 126.36 | 92.91 | 140.75 |